Mergers and acquisitions of German biotechnology startups

Holger Patzelt, Lars Schweizer, Dodo Zu Knyphausen-Aufseß

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

8 Zitate (Scopus)

Abstract

In research-intensive high-technology industries, it is often impossible for startup managers to build up internally all resources necessary for a successful company development. Hence, startups enter into strategic alliances with other companies or into mergers and acquisitions (M&As). Whereas alliances of startups are well studied in the literature, work on M&As mostly focuses on large corporations, but neglects deals between small entrepreneurial firms. In this exploratory study, we analyse six M&A cases of German biotechnology startups. We illustrate specific motives, benefits and problems associated with these deals. Our findings have implications for start-up managers and the future development of the German biotech industry.

OriginalspracheEnglisch
Seiten (von - bis)1-19
Seitenumfang19
FachzeitschriftInternational Journal of Biotechnology
Jahrgang9
Ausgabenummer1
DOIs
PublikationsstatusVeröffentlicht - 2007
Extern publiziertJa

Fingerprint

Untersuchen Sie die Forschungsthemen von „Mergers and acquisitions of German biotechnology startups“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren